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Since palliative sedation is considered a complex intervention, consultation teams are
increasingly established to support general practice. This study aims to offer insight into the
frequency and characteristics of expert consultations regarding palliative sedation.
Methods
We performed a retrospective analysis of a longitudinal database. This database contained
all patient-related consultations by Dutch Palliative Care Consultation teams, that were
requested between 2004 and 2011. We described the frequency and characteristics of
these consultations, in particular of the subgroup of consultations in which palliative seda-
tion was addressed (i.e. PSa consultations). We used multivariate regression analysis to
explore consultation characteristics associated with a higher likelihood of PSa
consultations.
Main Results and Their Significance
Of the 44,443 initial consultations, most were requested by general practitioners (73%) and
most concerned patients with cancer (86%). Palliative sedation was addressed in 18.1% of
all consultations. Palliative sedation was relatively more often discussed during consulta-
tions for patients with a neurologic disease (OR 1.79; 95% CI: 1.51–2.12) or COPD (OR
1.39; 95% CI: 1.15–1.69) than for patients with cancer. We observed a higher likelihood of
PSa consultations if the following topics were also addressed during consultation: dys-
pnoea (OR 1.30; 95% CI: 1.22–1.40), agitation/delirium (OR 1.57; 95% CI: 1.47–1.68),
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exhaustion (OR 2.89; 95% CI: 2.61–3.20), euthanasia-related questions (OR 2.65; 95% CI:
2.37–2.96) or existential issues (OR 1.55; 95% CI: 1.31–1.83).
Conclusion
In conclusion, PSa consultations accounted for almost one-fifth of all expert consultations
and were associated with several case-related characteristics. These characteristics may
help clinicians in identifying patients at risk for a more complex disease trajectory at the end
of life.
Introduction
Palliative sedation (PS) is commonly applied in end-of-life care, but its frequency and charac-
teristics vary between care settings and countries.[1–8] Palliative sedation involves the deliber-
ate lowering of consciousness in patients nearing death to relieve the burden of refractory
symptoms.[9] Refractory symptoms are “symptoms for which all possible treatment has failed,
or it is estimated that no methods are available for palliation within the time frame and the
risk-benefit ratio that the patient can tolerate”.[10] Because of the far-reaching consequences
of palliative sedation, it is considered a treatment option of last resort.[11]
To guide medical practice concerning palliative sedation, several guidelines and frameworks
have been published. Expert consultation is one of the topics addressed in these guidelines. For
example, the Dutch national guideline on palliative sedation advises consultation with an
“appropriate expert” when the attending physician lacks sufficient expertise and experience in
the field of palliative sedation.[12] Expert consultation in the context of palliative sedation is
also advocated by other frameworks and guidelines on palliative sedation, and some recom-
mend mandatory consultation.[13–19]
Previous research conducted in the Netherlands shows that guideline recommendations on
palliative sedation were increasingly applied in daily practice by Dutch physicians.[20] How-
ever, in the Netherlands, as well as in other countries, shortcomings were reported regarding
the intention to use palliative sedation, the adequate usage of medication and communication
with patients, informal caregivers and mutually between formal caregivers.[19–23] Further-
more, Swart et al. demonstrated that 41% of physicians believed that administering palliative
sedation had a life-shortening effect and that 14% had experienced pressure to commence
sedation, mainly from patients and their relatives.[24] Finally, it has been argued that individ-
ual general practitioners typically have little experience with palliative sedation in their case-
load.[12,25] Altogether, these findings suggest that there is a substantial need for expert
support concerning palliative sedation.
However, if expert consultation services are available, they seem to be used by health care
professionals in only a minority of palliative sedation cases.[26–29] Koper et al. investigated
considerations of Dutch physicians regarding expert consultations about palliative sedation.
Main reasons for physicians to consult specialist palliative care services for palliative sedation
are a lack of expertise and that consultation is considered supportive. Reasons not to use these
consultation services were as follows: physicians having sufficient expertise themselves; consid-
eration of palliative sedation as a normal medical procedure; time pressure; fear of disagree-
ment with the consultant; and considering consultation as having little added value.[30] An
alternative approach to gain additional insight in consultation practices concerning palliative
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sedation is to study, nationwide, the documentation of requested consultations at expert con-
sultation services.
Therefore, the aims of this study are to investigate the following over a period of 8 years: 1)
the frequency and characteristics of palliative care consultations given by Dutch Palliative Care
Consultation (PCC) teams, 2) the frequency and characteristics of consultations in which PS
was addressed, and 3) the consultation characteristics associated with a higher likelihood of PS
being addressed during consultation. These characteristic might help clinicians in identifying
patients at risk for a more complex disease trajectory at the end of life, for whom timely consul-
tation with an expert might be appropriate.
Materials and Methods
Design
We performed a retrospective analysis of a national database consisting of the registration of
all consultations by Dutch PCC teams that were requested between 2004 and 2011.
Setting
In 1998, the Dutch government installed a national program for the development and improve-
ment of palliative care. As a result of this program, regional PCC teams were established to
ensure the availability of specific advice concerning palliative care for all professional caregiv-
ers. In 2011, 23 PCC teams were available for expert consultation, covering the whole country.
PCC teams generally consist of general practitioners, medical specialists and specialized nurses
who are recruited from regional health centers and hospitals. PCC team members are practic-
ing healthcare professionals who have a special interest in palliative care and are trained in
such. Some PCC teams offer a 24/7-consultation service, while others are available for consul-
tation only during weekdays and to a limited extent during out-of-office hours. Most consulta-
tions were requested and answered by phone (approximately 90% in 2011).[31] Often, advice
given by consultants is previously discussed with one or more fellow consultants.[31,32] Rec-
ommendations are mainly communicated by phone and, as much as possible, confirmed in
writing. Only in a small minority of cases bedside consultations occur.[31] For each individual
consultation, consultants themselves registered their specific clinical findings, diagnosis, treat-
ment advice and other appointments in a national, standardized, web-based, consultation data-
base (PRADO, IKNL, Ecommany, the Netherlands).
Participants
In PRADO, a number of characteristics were systematically recorded for every consultation,
mainly using tick boxes: date of consultation, region of consultation, patient demographics
(date of birth, age, gender), diagnosis, estimated prognosis, listed symptoms and problems,
place of residence and the specialty or training of the professional caregiver requesting the con-
sultation. With regard to the listed problems, within PRADO the following sentence is dis-
played: “the consultation concerns the following problems. . .”. Subsequently, the consultant
lists one or more problems that have been addressed during consultation, using tick boxes.
“Palliative sedation”, is one of the options available in this list.
We grouped consultations based on whether or not “palliative sedation” was selected by the
consultant. As a result, two groups were defined: 1) consultations in which palliative sedation
was addressed by the consulting caregiver and/or the consultant and registered as such in
PRADO (PS addressed, abbreviated as PSa consultations), 2) other consultations (PS not
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addressed, abbreviated as PSna consultations). To prevent duplication of cases, we included
only the first consultation for every patient.
Statistical analysis and main outcome measures
Data were exported from the PRADO system into a Comma-Separated Value (CSV) file. Data
were anonymized and de-identified and were subsequently imported and analyzed in Stata,
Version 12.0 (StataCorp. 2011. Stata Statistical Software: Release 12. StataCorp LP, College Sta-
tion, Texas, United States).
The number of annual consultations for PCC teams was described and displayed as a per-
centage of the annual mortality rates as registered by Statistics Netherlands (CBS). Proportions
and 95% confidence intervals (95% CIs) were used to describe differences in characteristics
between PSa consultations and PSna consultations. Differences in characteristics were analyzed
for statistical significance using uni- and multivariate regression analysis. A p-level< 0.05 was
considered statistically significant.
Ethical considerations
The Committee on Research Involving Human Subjects (CMO) Region Arnhem-Nijmegen
stated that no further ethical assessment was required for this research. (Reg. 2013/423).
Informed consent was not obtained, since we only used data from an existing, clinical database,
that was anonymized and de-identified prior to analysis.
Results
General description of all palliative care consultations
During the study period, 44,443 first consultations were registered and included for analysis.
The vast majority of these consultations were requested by general practitioners (GPs) (72.7%)
and concerned patients residing at home (74.7%). Most patients enlisted for consultation were
diagnosed with cancer (86.1%). The most frequently listed symptoms were pain (45.0%), agita-
tion/delirium (15.4%), dyspnoea (15.4%), and nausea/vomiting (15.0%). Other topics fre-
quently addressed during consultation related to pharmacological questions (51.2%), moral
support for the professional caregivers themselves (33.7%) and issues about the organization of
care (23.7%). More than half of the consultations (56.8%) concerned patients with an estimated
prognosis of less than 4 weeks. The vast majority of consultations were requested during office
hours (85.0%) (Table 1). The annual consultation rate, in relation to the annual mortality num-
ber, rose during the first years of the study, from 3.6% (95% CI: 3.5%- 3.7%) in 2004 to 4.8%
(95% CI: 4.7%-4.9%) in 2006. After 2006, annual consultation rates declined until 2008 and
remained rather stable at approximately 4% afterwards (Table 2).
PSa consultations
Palliative sedation was addressed in 8,038 (18.1%) of the consultations. PSa consultations were
most often requested by GPs (87.4% of all PSa consultations, 7,023 PSa consultations) and
most often concerned patients diagnosed with cancer (82.1%, 6,597 PSa consultations). Since
86.1% (38,248 consultations) of all consultations concerned patients diagnosed with cancer,
the proportion of PSa consultations for this group of patients was relatively low (17.2%; 95%
CI: 16.9%-17.6%). Relatively high proportions of PSa consultations were found for patients
diagnosed with heart failure (25.0%; 95% CI: 22.5%-27.5%), neurologic diseases (22.9%; 95%
CI: 20.4%-25.4%), chronic obstructive pulmonary disease (COPD) (26.4%; 95% CI: 23.1%-
29.6%), and other diagnoses (23.8%; 95% CI: 22.1%-25.5%). Furthermore, palliative sedation
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Table 1. Characteristics of all consultations by Dutch PCC teams (2004–2011).
Variable All consultations PSa consultations Proportion of PSa
consultations*
n % n % % (95% CI)
Year of consultation
2004 4,851 10.9 509 6.3 10.5 (9.6–11.4)
2005 5,508 12.4 735 9.1 13.3 (12.4–14.2)
2006 6,465 14.6 1,178 14.6 18.2 (17.3–19.2)
2007 6,044 13.6 1,145 14.2 18.9 (18.0–19.9)
2008 5,283 11.9 1,127 14.0 21.3 (20.2–22.4)
2009 5,532 12.5 1,111 13.8 20.1 (19.0–21.1)
2010 5,638 12.7 1,125 14.0 20.0 (18.9–21.0)
2011 5,122 11.5 1,108 13.8 21.6 (20.5–22.8)
Consultation region
North 5,728 12.9 924 11.5 16.1 (15.2–17.1)
East 11,536 26.0 1,577 19.6 13.7 (13.0–14.3)
South 8,591 19.3 1,460 18.2 17.0 (16.2–17.8)
West 10,760 24.2 2,011 25.0 18.7 (18.0–19.4)
Middle 7,828 17.6 2,066 25.7 26.4 (25.4–27.4)
Consulting Professional Caregiver
General practitioner 32,319 72.7 7,023 87.4 21.7 (21.3–22.2)
Hospital specialist 2,666 6.0 196 2.4 7.4 (6.4–8.3)
Nurse 5,183 11.7 331 4.1 6.4 (5.7–7.1)
Elderly care physician 1,674 3.8 244 3.0 14.6 (12.9–16.3)
Other 2,586 5.8 242 3.0 9.4 (8.2–10.5)
Unknown 15 0.03 2 0.02 13.3 (-3.9–30.5)
Place of residence
Home 33,190 74.7 6,435 80.1 19.4 (19.0–19.8)
Hospice 2,874 6.5 516 6.4 18.0 (16.6–19.4)
Nursing/Residential Home 3,328 7.5 683 8.5 20.5 (19.2–21.9)
Hospital 4,008 9.0 271 3.4 6.8 (6.0–7.5)
Other 928 2.1 121 1.5 13.0 (10.9–15.2)
Unknown 115 0.3 12 0.2 10.4 (4.8–16.0)
Gender
Male 22,593 50.8 4,218 52.5 18.7 (18.2–19.2)
Female 21,804 49.1 3,813 47.4 17.5 (17.0–18.0)
Unknown 46 0.1 7 0.1 15.2 (4.8–25.6)
Age (years)
0–39 1,473 3.3 258 3.2 17.5 (15.6–19.5)
40–64 16,189 36.4 2,749 34.2 17.0 (16.4–17.6)
65–79 16,655 37.5 2,947 36.7 17.7 (17.1–18.3)
80 9,435 21.2 1,969 24.5 20.9 (20.0–21.7)
Unknown 691 1.6 115 1.4 16.6 (13.9–19.4)
Diagnosis
Cancer 38,248 86.1 6,597 82.1 17.2 (16.9–17.6)
Heart failure 1,135 2.6 284 3.5 25.0 (22.5–27.5)
Neurologic disease 1,065 2.4 244 3.0 22.9 (20.4–25.4)
Chronic obstructive pulmonary disease (COPD) 694 1.6 183 2.3 26.4 (23.1–29.6)
Other 2,477 5.6 590 7.3 23.8 (22.1–25.5)
(Continued)
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was relatively often addressed in consultations in which the following symptoms or issues were
also raised: exhaustion (proportion of PSa consultations: 28.7%; 95% CI: 27.1%-30.4%), agita-
tion/delirium (28.2%; 95% CI: 27.2%-29.3%), dyspnoea (25.2%; 95% CI: 24.2%-26.2%), eutha-
nasia-related (34.4%; 95% CI: 32.3%-36.5%), and existential issues (21.6%; 95% CI: 19.3%-
24.0%). Also, a relatively high proportion of PSa consultations was found for patients with an
estimated prognosis of less than 4 weeks (27.3%; 95% CI: 26.8%-27.9%). Finally, palliative seda-
tion was addressed relatively often in consultations outside of office hours (23.5%; 95% CI:
Table 1. (Continued)
Variable All consultations PSa consultations Proportion of PSa
consultations*
n % n % % (95% CI)
Unknown 824 1.9 140 1.7 17.0 (14.4–19.6)
Symptomsb
Anorexia 1,842 4.1 273 3.4 14.8 (13.2–16.4)
Dyspnoea 6,858 15.4 1,728 21.5 25.2 (24.2–26.2)
Agitation/delirium 6,857 15.4 1,937 24.1 28.2 (27.2–29.3)
Decubitus/ulcus 1,024 2.3 121 1.5 11.8 (9.8–13.8)
Depressed mood 3,268 7.4 370 4.6 11.3 (10.2–12.4)
Nausea/vomiting 6,680 15.0 899 11.2 13.5 (12.6–14.3)
Mouth problems 1,149 2.6 156 1.9 13.6 (11.6–15.6)
Constipation/diarrhea 2,168 4.9 206 2.6 9.5 (8.3–10.7)
Pain 19,977 45.0 2,924 36.4 14.6 (14.1–15.1)
Exhaustion 2,981 6.7 857 10.7 28.7 (27.1–30.4)
Other 8,412 18.9 1,463 18.2 17.4 (16.6–18.2)
Issuesb
Daily functioning 5,005 11.3 534 6.6 10.7 (9.8–11.5)
Euthanasia-related 1,981 4.4 682 8.5 34.4 (32.3–36.5)
Pharmacological 22,739 51.2 3,514 43.7 15.5 (15.0–15.9)
Informal care 3,501 7.9 429 5.3 12.3 (11.2–13.3)
Moral support professional caregiver 14,992 33.7 2,386 29.7 15.9 (15.3–16.5)
Organization of care 10,529 23.7 1,409 17.5 13.4 (12.7–14.0)
Social 2,593 5.8 249 3.1 9.6 (8.5–10.7)
Existential 1,175 2.6 254 3.2 21.6 (19.3–24.0)
Other 2,428 5.5 204 2.5 8.4 (7.3–9.5)
Estimated Prognosis
Less than 4 weeks 25,231 56.8 6,898 85.8 27.3 (26.8–27.9)
Between 4 weeks and 3 months 7,600 17.1 333 4.1 4.4 (3.9–4.8)
More than 3 months 3,394 7.6 82 1.0 2.4 (1.9–2.9)
Unknown 8,218 18.5 725 9.0 8.8 (8.2–9.4)
Time of consultation
Out-of-ofﬁce hours 6,377 14.4 1,497 18.6 23.5 (22.4–24.5)
Ofﬁce hours 37,763 85.0 6,509 80.1 17.2 (16.9–17.6)
Unknown 303 0.7 32 0.4 10.6 (7.1–14.0)
PCC teams: Palliative Care Consultation Team; PS: palliative sedation; PSa consultation: palliative sedation addressed during consultation; 95% CI:
95% conﬁdence interval.
a Proportion = (PSa consultations / total consultations)*100%, per single variable.
b Total of variables for “Symptoms” and “Issues” exceeds 100% due to more than one symptom / issue registered per consultation.
doi:10.1371/journal.pone.0136309.t001
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22.4%-24.5%) (Table 1). Over the years, palliative sedation was increasingly addressed during
PCC consultations, from 10.5% of cases in 2004 (95% CI: 9.6%-11.4%) to 21.6% of cases in
2011 (95% CI: 20.5%- 22.8%). PSa consultation rates as a percentage of annual mortality num-
bers varied between 0.4% in 2004 (95% CI: 0.3%-0.4%) to 0.9% in 2006 and 2007 (95% CI:
0.8%-0.9% for both years) (Table 2).
Multivariate regression analysis—characteristics associated with PSa
consultations
The following characteristics were associated with a higher likelihood of palliative sedation
being addressed during palliative care consultations: 1) patients being diagnosed with a neuro-
logic disease (OR 1.79, 95% CI: 1.51–2.12) or COPD (OR1.39, 95% CI: 1.15–1.69) compared to
cancer (reference variable) and 2) the presence of dyspnoea (OR 1.30, 95% CI: 1.22–1.40), agita-
tion/delirium (OR 1.57; 95% CI: 1.47–1.68), exhaustion (OR 2.89; 95% CI: 2.61–3.20), euthana-
sia-related issues (OR 2.65; 95% CI: 2.37–2.96) or existential issues (OR 1.55; 95% CI: 1.31–
1.83). The following characteristics were associated with a lower likelihood of palliative seda-
tion being addressed during consultations: 1) patients having a prognosis of more than 4 weeks
((OR 0.15 (95% CI: 0.13–0.16) for an estimated prognosis of “between 4 weeks and 3 months”
and 0.08 (95% CI: 0.06–0.10) for “more than 3 months,”, respectively), 2) professional caregiv-
ers other than the GP being the caregivers requesting consultation (OR varying from 0.36 for
nurses (95% CI: 0.32–0.41) to 0.61 for elderly care physicians (95% CI: 0.51–0.72)) and 3) the
timing of the consultation characterized as “during office hours” (OR 0.88; 95% CI: 0.82–0.95)
compared to “out-of-office hours” (reference variable) (Table 3).
Discussion
Main results
Palliative sedation was addressed in approximately one out of five palliative care consultations
in the Netherlands during the period 2004–2011. The likelihood of palliative sedation being
addressed during consultations was higher if the consultations were requested by GPs and dur-
ing “out of office” hours. Additionally, palliative sedation was relatively more often addressed
for patients with a non-cancer diagnosis, for patients with an estimated prognosis of less than 4
Table 2. Number of all consultations by Dutch PCC teams over the period 2004–2011.
AMN All consultations PSa consultations
n n % of AMN (95% CI) n % of AMN (95% CI)
Year of consultation
2004 136,553 4,851 3.6 (3.5–3.7) 509 0.4 (0.3–0.4)
2005 136,402 5,508 4.0 (3.9–4.1) 735 0.5 (0.5–0.6)
2006 135,372 6,465 4.8 (4.7–4.9) 1,178 0.9 (0.8–0.9)
2007 133,022 6,044 4.5 (4.4–4.7) 1,145 0.9 (0.8–0.9)
2008 135,136 5,283 3.9 (3.8–4.0) 1,127 0.8 (0.8–0.9)
2009 134,235 5,532 4.1 (4.0–4.2) 1,111 0.8 (0.8–0.9)
2010 136,058 5,638 4.1 (4.0–4.3) 1,125 0.8 (0.8–0.9)
2011 135,741 5,122 3.8 (3.7–3.9) 1,108 0.8 (0.8–0.9)
PCC teams: Palliative Care Consultation Teams; AMN: Annual Mortality Number; PS: palliative sedation; PSa consultation: palliative sedation
addressed during consultation; 95% CI: 95% conﬁdence interval.
doi:10.1371/journal.pone.0136309.t002
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Table 3. Univariate andmultivariate analysis of all consultations by Dutch PCC teams (2004–2011)–Characteristics associated with PSa
consultations.
Univariate analysis Multivariate analysis
Odds ratio (95% CI) Odds ratio (95% CI)
Year of consultation
2004 1 (reference) 1 (reference)
2005 1.31 (1.16–1.48) 1.41 (1.24–1.61)
2006 1.90 (1.70–2.12) 1.69 (1.49–1.91)
2007 1.99 (1.78–2.23) 1.66 (1.47–1.88)
2008 2.31 (2.07–2.59) 2.26 (1.99–2.57)
2009 2.14 (1.91–2.40) 2.11 (1.86–2.40)
2010 2.13 (1.90–2.38) 1.98 (1.74–2.24)
2011 2.35 (2.10–2.64) 2.17 (1.91–2.47)
Consultation region
North 1 (reference) 1 (reference)
East 0.82 (0.75 0.90) 0.90 (0.81–0.99)
South 1.06 (0.97–1.16) 1.28 (1.15–1.41)
West 1.20 (1.09–1.30) 1.19 (1.08–1.31)
Middle 1.86 (1.71–2.03) 1.42 (1.29–1.57)
Consulting professional caregiver
General practitioner 1 (reference) 1 (reference)
Hospital specialist 0.29 (0.25–0.33) 0.52 (0.42–0.64)
Nurse 0.25 (0.22–0.28) 0.36 (0.32–0.41)
Elderly care physician 0.61 (0.54–0.71) 0.61 (0.51–0.72)
Other 0.37 (0.32–0.43) 0.52 (0.45–0.61)
Unknown 0.55 (0.13–2.46) 0.78 (0.17–3.70)
Place of residence
Home 1 (reference) 1 (reference)
Hospice 0.91 (0.82–1.00) 1.09 (0.97–1.22)
Nursing/Residential home 1.07 (0.98–1.17) 1.02 (0.91–1.14)
Hospital 0.30 (0.27–0.34) 0.70 (0.59–0.84)
Other 0.62 (0.51–0.76) 0.85 (0.69–1.05)
Unknown 0.48 (0.27–0.88) 0.83 (0.43–1.58)
Gender
Male 1 (reference) 1 (reference)
Female 0.92 (0.88–0.97) 0.98 (0.93–1.03)
Unknown 0.78 (0.35–1.75) 1.11 (0.44–2.78)
Age (years)
0–39 1 (reference) 1 (reference)
40–64 0.96 (0.84–1.11) 0.93 (0.80–1.09)
65–79 1.01 (0.88–1.16) 0.93 (0.79–1.08)
 80 1.24 (1.07–1.43) 0.93 (0.80–1.10)
Unknown 0.94 (0.74–1.20) 1.09 (0.83–1.43)
Diagnosis
Cancer 1 (reference) 1 (reference)
Heart failure 1.60 (1.40–1.84) 1.15 (0.98–1.34)
Neurologic disease 1.43 (1.23–1.65) 1.79 (1.51–2.12)
Chronic obstructive pulmonary disease (COPD) 1.72 (1.45–2.04) 1.39 (1.15–1.69)
Other 1.50 (1.36–1.65) 1.53 (1.37–1.72)
(Continued)
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weeks, and for patients with dyspnoea, agitation/delirium, exhaustion, euthanasia-related or
existential issues.
Strengths and weaknesses
Amain strength of this study is the use of a national, standardized database containing all con-
sultations for Dutch PCC teams in the Netherlands that were provided and registered in the
period 2004 to 2011. By using this database, we were able to give a detailed overview of the
practice of palliative care consultations during this period. The number of missing values is low
(<2% of all cases per variable) for most variables. However, Schrijnemakers et al. demonstrated
Table 3. (Continued)
Univariate analysis Multivariate analysis
Odds ratio (95% CI) Odds ratio (95% CI)
Unknown 0.98 (0.82–1.18) 1.06 (0.87–1.31)
Symptoms (present)
Anorexia 0.78 (0.68–0.89) 1.13 (0.97–1.32)
Dyspnoea 1.67 (1.57–1.77) 1.30 (1.22–1.40)
Agitation/delirium 2.03 (1.91–2.16) 1.57 (1.47–1.68)
Decubitus/ulcus 0.60 (0.50–0.73) 0.87 (0.70–1.08)
Depressed mood 0.56 (0.50–0.62) 0.96 (0.84–1.09)
Nausea/vomiting 0.67 (0.62–0.72) 0.72 (0.67–0.79)
Mouth problems 0.71 (0.60–0.84) 0.92 (0.76–1.11)
Constipation/diarrhea 0.46 (0.40–0.53) 0.66 (0.56–0.77)
Pain 0.65 (0.62–0.68) 0.74 (0.70–0.78)
Exhaustion 1.93 (1.77–2.09) 2.89 (2.61–3.20)
Other 0.94 (0.89–1.00) 1.00 (0.93–1.08)
Issues (present)
Daily functioning 0.51 (0.46–0.56) 0.76 (0.69–0.85)
Euthanasia-related 2.51 (2.28–2.76) 2.65 (2.37–2.96)
Pharmacological 0.69 (0.66–0.73) 0.54 (0.51–0.58)
Informal care 0.61 (0.55–0.68) 1.09 (0.97–1.24)
Moral support professional caregiver 0.80 (0.76–0.84) 0.84 (0.79–0.90)
Organization of care 0.64 (0.60–0.68) 0.84 (0.78–0.90)
Social 0.46 (0.41–0.53) 0.87 (0.74–1.02)
Existential 1.26 (1.09–1.45) 1.55 (1.31–1.83)
Other 0.40 (0.35–0.46) 0.46 (0.39–0.53)
Prognosis
Less than 4 weeks 1 (reference) 1 (reference)
Between 4 weeks and 3 months 0.12 (0.11–0.14) 0.15 (0.13–0.16)
More than 3 months 0.07 (0.05–0.08) 0.08 (0.06–0.10)
Unknown 0.26 (0.24–0.28) 0.26 (0.24–0.28)
Time of consultation
Out-of-ofﬁce hours 1 (reference) 1 (reference)
Ofﬁce Hours 0.68 (0.64–0.72) 0.88 (0.82–0.95)
Unknown 0.38 (0.27–0.56) 1.02 (0.68–1.53)
PCC teams: Palliative Care Consultation Teams; PS: palliative sedation; PSa consultation: palliative sedation addressed during consultation; 95% CI:
95% conﬁdence interval.
doi:10.1371/journal.pone.0136309.t003
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that during telephone consultation a substantial share of the present problems may not be dis-
cussed and subsequently not be registered.[32]
Furthermore, to prevent duplication of patients with multiple consultations in our study
sample, we decided to include only the first consultation per patient. Consequently, follow-up
consultations in which palliative sedation may have been addressed were not included. Never-
theless, our final sample included 89.3% of all PSa consultations (8,038 out of 9,005 PSa consul-
tations) by Dutch PCC teams, which warrants the representativeness of our results. Another
consequence of the study methods used is that we were not able to study which percentage of
PSa consultations eventually led to the actual application of palliative sedation. Furthermore,
palliative sedation was defined in a general way, therefore no distinction could be made
between continuous and intermittent sedation. These factors hamper a comparison of our
study to the international literature concerning the practice and incidence of palliative seda-
tion. Also, since palliative sedation could only be registered by checking the tick-box “palliative
sedation”, no additional information was available on this topic (e.g. who initiated discussion
about palliative sedation?). Therefore PSa consultations may form a heterogeneous group of
consultations.
Finally, consultation rates from this study must be interpreted with caution because we have
studied only consultations delivered by PCC teams. Consequently, we did not take into account
alternative sources for palliative care consultations (e.g., hospital specialists or colleagues spe-
cialized in palliative care). Rietjens et al. showed that physicians, particularly clinical specialists,
but also 29% of the GPs, discuss sedation with other physicians rather than with a consultation
service.[29] These “unofficial” consultations are not taken into account in our study. This may
have led to an underestimation of consultation rates.
Comparison with the literature
We found an increase in PSa consultations over the period from 2004 to 2011. This appears to
be in line with previous research describing the incidence of palliative sedation in the Nether-
lands and Belgium.[3,4,33] The sharpest increase can be observed between 2005 and 2006.
This finding may be related to the publication of the guidelines on palliative sedation by the
Royal Dutch Medical Association (RDMA) in 2005, most likely leading towards an increased
awareness among practitioners.[20] In the Netherlands, the estimated incidence of (continu-
ous) palliative sedation in 2010 was 12.3% of all deaths.[3] Similar or higher percentages were
found in Belgium (14.5% in 2007) and the United Kingdom (18.7% in 2007/2008).[4,23,33] In
our study, the PSa consultation rate (PSa consultations as a percentage of the annual number
of deaths) in 2010 was 0.8%. This suggests one PSa consultation by PCC teams for every 15
cases of palliative sedation in the Netherlands (12.3%/0.8%). This rate is lower than the consul-
tation rate of 22% found by Swart et al.[24] One explanation for this different consultation
rate, could be that Swart et al. asked physicians whether they consulted any palliative care
team, whereas we only studied consultations requested at PCC teams. Anyhow, our finding
demonstrates that the use of PCC teams for palliative sedation seems not a common practice.
This rate is probably higher for general practitioners, as PSa consultations in our study were
mainly requested by general practitioners (87.4% of all PSa consultations), while, according to
the literature, general practitioners only perform almost half of all sedations.[34]
Our study raised three further topics that warrant discussion. First, dyspnoea, agitation/
delirium and exhaustion were significantly associated with a higher likelihood of palliative
sedation being addressed during consultation compared to other listed symptoms. A systematic
review by Maltoni et al. showed that the most common indication for palliative sedation is
delirium (54%) followed by dyspnoea (30%).[35] The complex management of these
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symptoms in end of life care is acknowledged in literature.[36,37] The finding that exhaustion
is associated with a higher likelihood of PSa consultations is in line with other research con-
ducted in the Netherlands, stating that exhaustion is a common indication to start palliative
sedation.[20,24] However, it is not mentioned as a common indication for palliative sedation
in recent international literature.[35] Furthermore, although pain is a commonly mentioned
symptom during PSa consultations (2,924 PSa consultations; 36.4%), resonating with the litera-
ture,[20,24,25] it is not independently associated with a higher likelihood of PSa consultations.
This might be a result of the overall high incidence of pain in all consultations requested at
PCC teams (19,977 consultations; 45.0%). As a result of this high denominator, the proportion
of PSa consultations is relatively low for pain.
Second, apart from symptoms, the underlying diagnosis appears relevant. Although cancer
accounts for the vast majority of palliative care consultations,[38] palliative sedation was dis-
cussed relatively more often for patients diagnosed with COPD and neurologic diseases. This
might be explained by the fact that patients with these diagnoses experience a relatively unpre-
dictable disease trajectory.[39,40] On the one hand, this may result in an increased risk of a
complex terminal trajectory with a higher chance at refractory symptoms and PSa consultation.
On the other hand, this may result in uncertainty regarding the estimated prognosis of patients
and the suitability of palliative sedation. It is therefore important that clinicians confronted
with patients with an end-stage COPD or neurologic disease prepare advanced care planning
for palliative care in time, including expert involvement.
Third, consultations in which existential issues were discussed were associated with a higher
likelihood of palliative sedation being addressed during consultation. The RDMA guideline on
palliative sedation recognizes that existential suffering may be among the refractory symptoms
that lead to unbearable suffering and state that expert consultations for these problems are
strongly recommended.[12] However, existential suffering as an indication for palliative seda-
tion remains controversial.[41] Previous research has shown that euthanasia, rather than palli-
ative sedation, is related to existential problems relatively often.[42] In this regard, it is also
important to notice that addressing “euthanasia-related issues” and palliative sedation were
highly interrelated in this study. PCC teams appear to have a role in supporting physicians to
explore palliative care options for patient cases in which questions concerning euthanasia, exis-
tential issues and palliative sedation intermingle. Clinicians confronted with existential suffer-
ing in end-of-life care are therefore encouraged to seek support from expert teams to prevent
palliative sedation being applied for controversial indications.
Conclusion
Expert consultation in the field of palliative sedation is advocated when physicians lack suffi-
cient knowledge or expertise in the field of palliative sedation. However, mandatory consulta-
tion for palliative sedation, as argued by some, remains an ongoing debate in the recent
literature.[30,43] From our study, the use of expert consultation services for palliative sedation
does not appear to be a common practice. This might indicate a limited need for expert consul-
tation as a result of physicians being sufficiently skilled in this area. It might also point to an
already covered need for expert consultation provided by other healthcare professionals beyond
regular consultation services. Finally, there might be a neglected need for expert consultations
due to physicians being unaware of their limited expertise concerning palliative sedation. Fur-
ther research is needed here.
Consultation rates for palliative sedation appear to be rather low. To verify the accuracy of
these consultation rates, future research must reveal the use of expert consultation services
other than established PCC teams. In addition, future research should yield more insight into
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the needs of general practitioners concerning palliative sedation, which could guide current
palliative care consultation teams in adapting their services to these needs. This might lead to
an increase in consultation rates and eventually improve the practice of palliative sedation.
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